Which super funds hold Guangzhou Baiyunshan Pharmaceutical Holdings Co Ltd?
As at 31 December 2025, 13 Australian super investment options in our dataset held Guangzhou Baiyunshan Pharmaceutical Holdings Co Ltd, the largest weighting being 0.00% in Balanced (Accumulation) (AustralianSuper).
Options holding it
13
Largest weighting
0.00%
Balanced (Accumulation) · AustralianSuper
Australian super investment options disclosing a holding in Guangzhou Baiyunshan Pharmaceutical Holdings Co Ltd. Figures aggregate each option's disclosed line items for this security, as at each option's own reporting date.
| Fund | Phase | Option | Weighting | Value (AUD) | As at |
|---|---|---|---|---|---|
| AustralianSuper | Accumulation | Balanced (Accumulation) | 0.00% | $3,187,503 | 31 December 2025 |
| AustralianSuper | Accumulation | High Growth (Accumulation) | 0.00% | $715,726 | 31 December 2025 |
| AustralianSuper | Retirement | Balanced (Income) | 0.00% | $422,130 | 31 December 2025 |
| AustralianSuper | Accumulation | International Shares (Accumulation) | 0.00% | $374,695 | 31 December 2025 |
| Aware Super | Retirement | Conservative Balanced (Income) | 0.00% | $130,858 | 31 December 2025 |
| AustralianSuper | Retirement | Conservative Balanced (Income) | 0.00% | $87,503 | 31 December 2025 |
| AustralianSuper | Accumulation | Conservative Balanced (Accumulation) | 0.00% | $72,175 | 31 December 2025 |
| AustralianSuper | Retirement | International Shares (Income) | 0.00% | $55,803 | 31 December 2025 |
| AustralianSuper | Retirement | High Growth (Income) | 0.00% | $48,433 | 31 December 2025 |
| AustralianSuper | Accumulation | Stable (Accumulation) | 0.00% | $30,187 | 31 December 2025 |
| Aware Super | Retirement | Conservative (Income) | 0.00% | $29,454 | 31 December 2025 |
| AustralianSuper | Retirement | Stable (Income) | 0.00% | $27,806 | 31 December 2025 |
| Aware Super | Retirement | Defensive (Income) | 0.00% | $10,386 | 31 December 2025 |
This page surfaces figures disclosed by the funds themselves under Portfolio Holdings Disclosure (Schedule 8D), each as at the date shown. It is factual disclosure information, not financial advice or a recommendation.
Methodology — how holdings are sourced, resolved and aggregated.